A detailed history of Ameriprise Financial Inc transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 520,868 shares of LNTH stock, worth $42.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
520,868
Previous 239,829 117.18%
Holding current value
$42.1 Million
Previous $19.3 Million 196.88%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$77.7 - $123.62 $21.8 Million - $34.7 Million
281,039 Added 117.18%
520,868 $57.2 Million
Q2 2024

Aug 14, 2024

SELL
$58.87 - $83.05 $344,978 - $486,673
-5,860 Reduced 2.39%
239,829 $19.3 Million
Q1 2024

May 15, 2024

BUY
$51.07 - $68.26 $530,259 - $708,743
10,383 Added 4.41%
245,689 $15.3 Million
Q4 2023

Feb 14, 2024

SELL
$55.6 - $77.89 $157,459 - $220,584
-2,832 Reduced 1.19%
235,306 $14.6 Million
Q3 2023

Nov 14, 2023

BUY
$60.27 - $90.75 $1.99 Million - $3 Million
33,025 Added 16.1%
238,138 $16.5 Million
Q2 2023

Aug 14, 2023

SELL
$82.41 - $99.65 $1.4 Million - $1.7 Million
-17,023 Reduced 7.66%
205,113 $17.2 Million
Q1 2023

May 15, 2023

BUY
$47.76 - $82.86 $1.39 Million - $2.41 Million
29,033 Added 15.03%
222,136 $18.3 Million
Q4 2022

Feb 14, 2023

SELL
$48.76 - $77.67 $7.42 Million - $11.8 Million
-152,238 Reduced 44.08%
193,103 $9.84 Million
Q3 2022

Nov 14, 2022

SELL
$61.42 - $86.29 $1.92 Million - $2.7 Million
-31,252 Reduced 8.3%
345,341 $24.3 Million
Q2 2022

Aug 15, 2022

SELL
$55.54 - $72.65 $1.59 Million - $2.08 Million
-28,587 Reduced 7.06%
376,593 $24.9 Million
Q1 2022

May 16, 2022

SELL
$24.28 - $56.64 $2.46 Million - $5.75 Million
-101,519 Reduced 20.04%
405,180 $22.4 Million
Q4 2021

Feb 14, 2022

SELL
$22.54 - $30.44 $1.98 Million - $2.67 Million
-87,695 Reduced 14.75%
506,699 $14.6 Million
Q3 2021

Nov 15, 2021

BUY
$24.23 - $28.59 $672,794 - $793,858
27,767 Added 4.9%
594,394 $15.3 Million
Q2 2021

Aug 16, 2021

BUY
$19.51 - $27.64 $4.57 Million - $6.48 Million
234,445 Added 70.58%
566,627 $15.7 Million
Q1 2021

May 17, 2021

BUY
$13.77 - $21.66 $649,627 - $1.02 Million
47,177 Added 16.55%
332,182 $7.1 Million
Q4 2020

Feb 12, 2021

SELL
$10.75 - $14.91 $271,695 - $376,835
-25,274 Reduced 8.15%
285,005 $3.85 Million
Q3 2020

Nov 16, 2020

SELL
$11.98 - $16.34 $957,082 - $1.31 Million
-79,890 Reduced 20.48%
310,279 $3.93 Million
Q2 2020

Aug 14, 2020

BUY
$10.34 - $15.51 $313,467 - $470,201
30,316 Added 8.42%
390,169 $5.58 Million
Q1 2020

May 15, 2020

SELL
$9.11 - $20.05 $691,640 - $1.52 Million
-75,921 Reduced 17.42%
359,853 $4.59 Million
Q4 2019

Feb 14, 2020

SELL
$18.47 - $24.03 $639,505 - $832,014
-34,624 Reduced 7.36%
435,774 $8.94 Million
Q3 2019

Nov 14, 2019

SELL
$21.01 - $28.94 $2.07 Million - $2.85 Million
-98,375 Reduced 17.3%
470,398 $11.8 Million
Q2 2019

Aug 14, 2019

BUY
$23.33 - $28.3 $700,389 - $849,594
30,021 Added 5.57%
568,773 $16.1 Million
Q1 2019

May 15, 2019

SELL
$14.93 - $25.1 $113,871 - $191,437
-7,627 Reduced 1.4%
538,752 $13.2 Million
Q4 2018

Feb 14, 2019

BUY
$12.68 - $19.01 $1.59 Million - $2.38 Million
125,395 Added 29.79%
546,379 $8.55 Million
Q3 2018

Nov 14, 2018

SELL
$13.1 - $16.35 $110,498 - $137,912
-8,435 Reduced 1.96%
420,984 $6.29 Million
Q2 2018

Aug 14, 2018

SELL
$13.65 - $18.7 $1.66 Million - $2.28 Million
-121,809 Reduced 22.1%
429,419 $6.25 Million
Q1 2018

May 15, 2018

BUY
$14.85 - $24.3 $1.84 Million - $3.01 Million
123,756 Added 28.95%
551,228 $8.76 Million
Q4 2017

Feb 12, 2018

SELL
$17.4 - $23.4 $587,076 - $789,516
-33,740 Reduced 7.32%
427,472 $8.74 Million
Q3 2017

Nov 07, 2017

BUY
$15.5 - $19.15 $7.15 Million - $8.83 Million
461,212
461,212 $8.21 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $5.56B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.